tiprankstipranks
Trending News
More News >
Aktis Oncology, Inc. (AKTS)
NASDAQ:AKTS
US Market

Aktis Oncology, Inc. (AKTS) Income Statement

Compare
17 Followers

Aktis Oncology, Inc. Income Statement

Last quarter (Q4 2024), Aktis Oncology, Inc.'s total revenue was $933.00K. In Q4, Aktis Oncology, Inc.'s net income was $-12.06M. See Aktis Oncology, Inc.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22
Total Revenue
$ 1.49M$ 0.00$ 0.00
Gross Profit
$ 1.49M$ 0.00$ 0.00
Operating Expenses
$ 53.54M$ 34.79M$ 19.76M
Depreciation and Amortization
$ 1.57M$ 1.20M$ 445.00K
EBITDA
$ -50.48M$ -33.60M$ -19.32M
Operating Income
$ -52.05M$ -34.79M$ -19.76M
Other Income/Expenses
$ 8.07M$ 6.15M$ 1.83M
Pretax Income
$ -43.98M$ -28.64M$ -17.93M
Net Income
$ -43.98M$ -28.64M$ -17.93M
Per Share Metrics
Basic EPS
$ 0.00$ 0.00$ 0.00
Diluted EPS
$ 0.00$ 0.00$ 0.00
Weighted Average Shares Outstanding
0.00 0.00 0.00
Weighted Average Shares Outstanding (Diluted)
0.00 0.00 0.00
Currency in USD

Aktis Oncology, Inc. Earnings and Revenue History